Literature DB >> 21723899

A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression.

S D Isidean1, M S Riddle, S J Savarino, C K Porter.   

Abstract

INTRODUCTION: Vaccine development for enterotoxigenic Escherichia coli (ETEC) is dependent on in-depth understanding of toxin and colonization factor (CF) distribution. We sought to describe ETEC epidemiology across regions and populations, focusing on CF and toxin prevalence.
METHODS: We conducted a systematic review of the published literature, including studies reporting data on ETEC CF and toxin distributions among those with ETEC infection. Point estimates and confidence intervals were calculated using random effects models.
RESULTS: Data on 17,205 ETEC isolates were abstracted from 136 included studies. Approximately half of the studies (49%) involved endemic populations, and an additional 17% involved only travel populations. Globally, 60% of isolates expressed LT either alone (27%) or in combination with ST (33%). CFA/I-expressing strains were common in all regions (17%), as were ETEC expressing CFA/II (9%) and IV (18%). Marked variation in toxins and CFs across regions and populations was observed. DISCUSSION/
CONCLUSIONS: These results demonstrate the relative importance of specific CFs in achieving target product profiles for a future ETEC vaccine. However, heterogeneity across time, population, and region, confounded by variability in CF and toxin detection methodologies, obfuscates rational estimates for valency requirements. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723899     DOI: 10.1016/j.vaccine.2011.06.084

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  106 in total

1.  The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.

Authors:  S J M Ten Bruggencate; S A Girard; E G M Floris-Vollenbroek; R Bhardwaj; T A Tompkins
Journal:  Eur J Clin Nutr       Date:  2014-11-05       Impact factor: 4.016

2.  Enterotoxigenic Escherichia coli CS21 pilus contributes to adhesion to intestinal cells and to pathogenesis under in vivo conditions.

Authors:  C P Guevara; W B Luiz; A Sierra; C Cruz; F Qadri; R S Kaushik; L C S Ferreira; O G Gómez-Duarte
Journal:  Microbiology       Date:  2013-06-12       Impact factor: 2.777

3.  Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.

Authors:  Milton Maciel; David Bauer; Robin L Baudier; Jacob Bitoun; John D Clements; Steven T Poole; Mark A Smith; Robert W Kaminski; Stephen J Savarino; Elizabeth B Norton
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 4.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development.

Authors:  James M Fleckenstein
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

6.  Archaic and alternative chaperones preserve pilin folding energy by providing incomplete structural information.

Authors:  Natalia Pakharukova; Sophie McKenna; Minna Tuittila; Sari Paavilainen; Henri Malmi; Yingqi Xu; Olena Parilova; Steve Matthews; Anton V Zavialov
Journal:  J Biol Chem       Date:  2018-09-18       Impact factor: 5.157

7.  Biochemical and Immunological Evaluation of Recombinant CS6-Derived Subunit Enterotoxigenic Escherichia coli Vaccine Candidates.

Authors:  Steven T Poole; Milton Maciel; Premkumar Dinadayala; Kathleen E Dori; Annette L McVeigh; Yang Liu; Eileen Barry; Christen Grassel; Michael G Prouty; Geneviève Renauld-Mongénie; Stephen J Savarino
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

Review 8.  [Acute diarrheal disease caused by enteropathogenic Escherichia coli in Colombia].

Authors:  Oscar G Gómez-Duarte
Journal:  Rev Chilena Infectol       Date:  2014-10       Impact factor: 0.520

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

10.  Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.

Authors:  Aisling O'Dowd; Milton Maciel; Steven T Poole; Michael G Jobling; Julianne E Rollenhagen; Colleen M Woods; Stephanie A Sincock; Annette L McVeigh; Michael J Gregory; Ryan C Maves; Michael G Prouty; Randall K Holmes; Stephen J Savarino
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.